by Eli L. Diamond, Omar Abdel-Wahab, Benjamin H

Slides:



Advertisements
Similar presentations
NRAS Q61R Mutation in Erdheim-Chester Disease Accompanying by Myeloid Neoplasia: Evidence for a Possible Clonal Relationship Neval Ozkaya M.D.1, Benjamin.
Advertisements

Nat. Rev. Neurol. doi: /nrneurol
How I treat extramedullary myeloma
by Eli L. Diamond, Lorenzo Dagna, David M
Silent Brain Infarcts by Yi-Cheng Zhu, Carole Dufouil, Christophe Tzourio, and Hugues Chabriat Stroke Volume 42(4): March 28, 2011 Copyright ©
Figure 1 Perivenous distribution of multiple sclerosis lesions
Jenny Dave, MS, Mark A. Ahlman, MD, Benjamin N. Lockshin, MD, David A
Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy by Georg.
by Thomas S. Uldrick, and Richard F. Little
Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle.
How I treat elderly patients with myeloma
Figure 3 Brain MRI findings in patients with MOG-Ab Extensive brain lesions with large diameter (A and B), posterior reversible encephalopathy–like lesions.
Fusion genes in cord blood
Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Young Adult Male in a Coma
Figure 2 Evolution of MRI abnormalities in faciobrachial dystonic seizures Axial fluid- attenuated inversion recovery (FLAIR)-weighted images from patient.
Figure Facial photograph during headache attack and brain and upper cervical cord MRI Facial photograph during headache attack and brain and upper cervical.
Axial magnetic resonance (MR) imaging
Figure 3 Example of venous narrowing
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Figure 1 MRI head in faciobrachial dystonic seizures (A) Axial fluid-attenuated inversion recovery image from patient 3 in table 2 shows T2-weighted hyperintensity.
Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement  Ahmed Al Bayati, MD, Thomas Plate, MD, Mahmood Al Bayati,
Figure 2 Exemplary MRI of a patient with contrast enhancement on postcontrast FLAIR MRI of a 54-year-old patient with viral meningitis caused by varicella-zoster.
Brain and spine MR imaging of a 48-year-old woman with Zika virus infection and encephalitis and myelitis. Brain and spine MR imaging of a 48-year-old.
Figure Radiologic and pathologic findings Fluid-attenuated inversion recovery (FLAIR) sequence with a single large T2-hyperintense signal involving the.
Axial computed tomography (CT) images a) at baseline and b) at a 12-month follow-up scan, in a patient with idiopathic pulmonary fibrosis (IPF). b) Note.
Figure 2 Example of venous narrowing
Axial CT scans of the chest. a) Before treatment
Serial computed tomography (CT) imaging for monitoring disease progression in patients with idiopathic pulmonary fibrosis. Serial computed tomography (CT)
Figure Genetic deletion and MRI changes with EHMT1 deletion
The clinical spectrum of Erdheim-Chester disease: an observational cohort study by Juvianee I. Estrada-Veras, Kevin J. O’Brien, Louisa C. Boyd, Rahul H.
Case 5. Case 5. Organized hematoma of the maxillary sinus in a 50-year-old man. A, Precontrast axial CT scan with bone algorithm shows a large, expansile.
Fig F-FGln shows uptake in human gliomas undergoing progression.
Figure Postcontrast axial and coronal brain MRI in a patient with CLIPPERS treated with hydroxychloroquineT1-weighted spin echo post IV gadolinium contrast.
Figure 1 Evolution of MRI findings during interleukin (IL)–7 therapy
Positron emission tomography/computed tomography scans showed a mass lesion. a) Areas of cavitation were noted in the left lower lobe, encasing the segmental.
Figure 1 Imaging of disease onset and treatment response Repeat MRI scans including fluid-attenuated inversion recovery (FLAIR) (A) and T2 fast field echo.
by Elizabeth C. Neil, and Lisa M. DeAngelis
Figure 1 MRI findings over time
Figure Imaging, histology/immunohistochemistry, and schematic course of treatment with corresponding clinical and radiologic disease activity Imaging,
Figure 1 Brain MRI Brain MRI (A) Axial fluid-attenuated inversion-recovery images show perilesional edema in both cerebellar hemisphere and hypointense.
Axial CT images at the level of the middle cerebellar peduncles show blood clot within the fourth ventricle. Axial CT images at the level of the middle.
A–C, Selected axial CT scans demonstrate dystrophic calcification of the subcortical arcuate fibers, globus pallidus, pulvinar, and cerebellar corticomedullary.
Patient 5, a 33-year-old man presenting with severe headache and sinus congestion. Patient 5, a 33-year-old man presenting with severe headache and sinus.
Figure Spinal cord imaging (A, B) Sagittal and axial T2-weighted cervical spine MRI demonstrating hyperintensities in the central gray matter of patient.
A 50-year-old male with persistent abnormality on computed tomography (CT) despite anticoagulation for 1 year. a) CT scan showing an expansile low attenuation.
Case 10. Case 10. Organized hematoma of the maxillary sinus in a 76-year-old woman. A, Precontrast axial CT scan with bone window setting shows a large,
Patient 5. Patient 5. Initial axial, half cut, and magnified MR images of a 39-year-old man with spontaneous intracranial hypotension who presented with.
Patient 12. Patient 12. A 43-year-old woman with headache, blurred vision, and mental status change.A, T2-weighted axial MR image shows bilateral centrum.
Figure 1 Imaging and histopathologic characteristics of patients with CNS-FHL Imaging and histopathologic characteristics of patients with CNS-FHL FLAIR.
Figure Rapid progression of lesions after natalizumab treatment(A) MRI from February Rapid progression of lesions after natalizumab treatment(A)
Figure A 57-year-old man with relapsing-remitting MS (RRMS) and new-onset ataxia A 57-year-old man with relapsing-remitting MS (RRMS) and new-onset ataxia.
Figure 4 Patient 3 MRI evolution over time
A and B, CT images on a patient status post total thyroidectomy for thyroid cancer show a small enhancing lesion near the right tracheoesophageal groove.
Patient 1. Patient 1. Axial fluid-attenuated inversion recovery (FLAIR) imaging (A), diffusion-weighted imaging (DWI) (B), and apparent diffusion coefficient.
Figure 2 Patient 1 MRI evolution over time
Images of Patient 5, a 35-year-old woman with chordoid glioma.
Sagittal midline T1-weighted (A) and coronal fluid-attenuated (B) inversion recovery (C) images demonstrate evidence of progressive cerebellar atrophy.
MR images of the brain (axial sections, fluid-attenuated reversion recovery sequences) show the symmetric hyperintensities (arrows) involving the pyramidal.
Figure 1 MRI at presentation The axial diffusion-weighted image (A) showed restricted diffusion throughout the cortical ribbon of the right hemisphere.
The “white gray sign.” Axial high-resolution 3D inversion recovery fast-spoiled gradient-echo T1-weighted image demonstrates decreased gray-white contrast.
On follow-up MR examination, 25 days after onset of symptoms, T2-weighted (A) and fluid-attenuated inversion recovery (B) MR images of brain show neuronal.
Patient 10. Patient 10. A 67-year-old man after radiation therapy at an outside hospital for base-of-tongue cancer. A and B, Axial contrast-enhanced CT.
Coronal inversion recovery (A) demonstrates symmetric abnormal hyperintense signal within the bilateral distal femoral metaphyses (arrows) in A with corresponding.
A. A. Computed tomographic (CT) scan, epidural hematoma, B. CT scan, subdural hematoma. C. CT scan, subarachnoid hemorrhage. D. Magnetic resonance image.
by Christian Grommes, Sarah S. Tang, Julia Wolfe, Thomas J
Patient 4, a 72-year-old man presenting with headache, dysphagia, and progressive hoarseness. Patient 4, a 72-year-old man presenting with headache, dysphagia,
Therapeutic efficacy of MEK and RAF inhibition in patients with MAP2K1- and ARAF-mutant systemic histiocytic neoplasms. Therapeutic efficacy of MEK and.
Corticobasal degeneration (CBD), case 3.
KD involving bilateral buccal spaces in a 52-year-old man.
Presentation transcript:

Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease by Eli L. Diamond, Omar Abdel-Wahab, Benjamin H. Durham, Ahmet Dogan, Neval Ozkaya, Lynn Brody, Maria Arcila, Christian Bowers, and Mark Fluchel Blood Volume 128(14):1896-1898 October 6, 2016 ©2016 by American Society of Hematology

Perinephric tissue. Perinephric tissue. Patient 1 with a CD68+ histiocytic infiltrate with admixed fibrosis (A). Axial T2-fluid attenuation inversion recovery MRI images demonstrate scattered lesions in the brainstem and cerebellar peduncles (yellow arrows) (B), and these are resolved after 6 months of treatment (C). A representative FDG-avid (SUV 3.1) periarterial lesion (D, upper) has resolved to background uptake (D, lower). Sclerotic lesions from the distal femur of patient 2 (E). Expansile meningeal infiltrations are demonstrated by axial postgadolinium T1-weighted MRI scan (red arrow) before treatment (F) and then are resolved 2 years into anakinra therapy (G). Eli L. Diamond et al. Blood 2016;128:1896-1898 ©2016 by American Society of Hematology